© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
660376 |
As an accredited 4-Bromopyridin-2-Ol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromopyridin-2-Ol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists and researchers who regularly work at the intersection of heterocyclic chemistry and pharmaceutical design often find gaps in available building blocks. Too often, lab shelves are lined with rote reagents lacking the versatility that nuanced synthesis actually demands. That’s where a compound like 4-Bromopyridin-2-Ol comes in: it fills a distinctive niche, delivers reliability, and proves its value in circumstances where others fall short.
Not all pyridinol derivatives step up in the same way across multiple fields. 4-Bromopyridin-2-Ol, with its balanced aromatic structure, enables transformations unreachable with unsubstituted pyridines or more standard bromo analogs. The bromine atom anchored to the fourth position of the pyridin-2-ol ring opens up a world of targeted substitutions, whether you’re aiming to build more elaborate rings, add functionalities, or explore new routes in medicinal chemistry.
Having worked in small molecule synthesis for the better part of a decade, I know how tedious it can be to navigate the limitations of one-size-fits-all intermediates. More than once, a limited starting point meant a never-ending run of re-optimizations that wasted valuable time and resources. Unlike run-of-the-mill bromo-pyridines, this specific compound provides both reactivity and selectivity, giving practitioners more leverage for both routine and high-stakes projects.
4-Bromopyridin-2-Ol bears the molecular formula C5H4BrNO. Chemically, its configuration means it carries both bromine and hydroxyl substituents positioned to steer reactivity in predictable, controllable ways. The hydroxyl group at the second ring position stabilizes intermediates, often granting greater solubility or modulating acidity compared with non-hydroxy analogues.
What stands out to many synthetic chemists is the tight melting range and high level of purity typically available with this compound. Clean crystallization and uncomplicated chromatography results follow careful supplier selection, reducing batch-to-batch variation, which is critical for reproducibility. In actual practice, even slight differences in purity or solvent residues can completely change the outcome of a step in multi-stage syntheses, so reliable sourcing remains essential.
Many chemists first encounter 4-Bromopyridin-2-Ol during cross-coupling reactions. Suzuki, Stille, and Buchwald-Hartwig techniques can often benefit from the controlled reactivity of this bromo group, allowing for the installation of aryl or amine moieties without unwanted side-products. Working on the bench, a trusted supply of this compound allows teams to push scope in fragment-based drug design or library generation with confidence instead of apprehension.
Beyond strictly organic transformations, this molecule finds a home in areas like materials research and ligand design for metal catalysis. The interplay between its bromine and hydroxyl functionalities allows it to bridge into coordination chemistry or surface modification projects—spaces generally dominated by more specialized, more expensive reagents. I’ve personally seen its flexibility shave weeks off project timelines when the team had the foresight to keep it on hand.
Anyone who has tried to substitute a plain bromopyridine or a simple pyridone knows the headaches associated with unbalanced reactivity. Introducing a hydroxyl group alongside bromine at the right position shifts the behavior meaningfully. The electron-donating effect of the hydroxyl alters aromatic substitution patterns, while the bromine acts as a robust handle for further cross-coupling or functionalization.
In survey after survey, chemists point to the need for intermediates that can remain stable on the shelf but still react energetically in the flask, and 4-Bromopyridin-2-Ol offers that rare combination. By comparison, analogues where the bromine is misplaced or the hydroxyl group is missing tend not to offer the same clean selectivity or intermediate stability. Having access to reagents that perform under the pressure of scale-ups as well as under tight budget constraints is a genuine advantage.
Every year, the pressure for novel drug candidates and advanced functional materials grows stronger. Creative synthetic pathways need more than just standard blocks—they need molecules that can withstand changes in protocol or shifts in project scope. I’ve seen the disappointment on researchers’ faces when less versatile compounds bottleneck an otherwise promising route. 4-Bromopyridin-2-Ol breaks through these bottlenecks, providing the kind of pivot point most protocols now require for modern production.
Regulatory scrutiny surrounding new substances grows each year. While 4-Bromopyridin-2-Ol doesn’t solve every compliance issue on its own, taking care with purity, provenance, and transparent supply chains makes working with this reagent much less risky than resorting to obscure, less-characterized chemicals. Relying on less frequently documented molecules often leaves projects vulnerable to audit headaches or escalated registration costs—not ideal for small labs.
Drawing from the lived experience of hundreds of synthesis runs, I recommend sourcing this product from suppliers who publish realistic spectra and QC reports. While no lab wants to run extra checks, cutting corners generally means more downtime once you actually need to submit your project for review or scale it beyond bench scale. I’ve seen colleagues spend more time tracking down the sources of trace contaminants than progressing their research; a consistent, transparent supply chain can help avoid these headaches.
In many instances, simply knowing that a compound can serve dual purposes—such as being both a precursor for cross-coupling and an intermediate for heterocycle construction—opens doors that off-the-shelf pyridines simply can’t. Embedding flexibility into the purchase list allows research managers and procurement teams to justify inventory in tight funding cycles, and also keeps discovery work agile when project directions change overnight.
Feedback from teams working on kinase inhibitor scaffolds confirms the compound’s role in early-phase discovery. Substituent patterns found in medicinal chemistry patents often reflect the same positions offered by the 4-bromo, 2-hydroxy motif. The presence of both reactivity and stability helps teams quickly cycle through structure-activity relationship studies without hunting for substitute reagents at every fork in the project.
Screening for new OLED or photovoltaic materials also benefits from intermediates like this one. Groups working in electronic device research rely on the tunability of heterocyclic systems, and this compound matches their criteria for introducing controlled electronic effects into larger frameworks. Materials groups enjoy the lower cost compared with some more exotic nitrogen heterocycles and benefit from the established handling and disposal practices already documented for pyridine systems.
Even reliable reagents can introduce headaches without the right infrastructure. For 4-Bromopyridin-2-Ol, storage should be cool and dry, much like any pyridine derivative prone to hydrolysis or oxidative degradation. Toxicity and volatility concerns match broadly with other bromoaromatic compounds, so standard laboratory precautions translate well.
One recurring pitfall: certain solvents and bases trigger unwanted side-reactions. Ensuring your team has access to up-to-date compatibility tables can save on wasted starting material. Keeping a dry, oxygen-free environment also avoids the formation of colored byproducts. While these points seem routine, even experienced researchers sometimes ignore them in the rush of a fast-paced synthesis campaign, leading to unnecessary delays.
Sourcing questions matter, too. Poor handling during shipping contributes to batch inconsistency, so it pays to develop a working relationship with your supplier. Some vendors work with local warehouses or in-country inventory, which helps shield buyers from international supply chain hiccups. Getting a consistent product means fewer repeats, resubmissions, and headaches come publication or patenting time.
Bringing 4-Bromopyridin-2-Ol into the active reagent set changes the rhythm of a project. Colleagues working on iterative drug discovery say having it in stock means days saved on ordering new precursors, as well as confidence in scale-up procedures. The hydroxyl group aids purification downstream, often translating to less time lost on columns or crystallizations. Process chemists gearing up for larger scale operations often look for compounds like this precisely because their stability and handling requirements dovetail cleanly with standard operating procedures.
Environmental and safety managers in growing labs appreciate the straightforward waste handling profile. The chemistry echoes established pathways for both pyridines and aryl bromides, which means standard disposal practices apply. Simple documentation on storage, handling, and accident response fits into the established routines at most teaching and research labs.
On a practical level, the presence of both bromo and hydroxy in a single molecule means one less step in a typical multi-stage pathway. Combining functionality at the right positions trims unnecessary synthesis, reducing reagent waste and analytical workload. This approach takes on greater significance as academic and industrial funding tightens, favoring leaner, more efficient research cycles. Regular users of this compound testify to the time saved on iterative syntheses of analog libraries.
For project leads who need to justify reagent purchases to finance departments or upper management, showing the double utility of 4-Bromopyridin-2-Ol makes budget negotiations easier. Fewer line items, more flexibility, and lower risk of project interruption translate to higher ROI for the bench and the ledger.
In the era of quality-driven research, transparency in ingredient sourcing matters as much as reactivity in the flask. Teams with regulatory review ahead benefit from detailed documentation on synthesis and handling—sources who share this information openly build trust and save researchers paperwork trouble. From the perspective of a lab manager, being able to trace each bottle back to a robust supply chain matters during regulatory audits.
Collaborative work, especially among cross-disciplinary teams, also benefits from transparent reagents. Knowing the full history and handling of a batch avoids duplication of effort, eases the process of writing up results, and helps when unexpected issues come up during patenting or scale-up.
Innovation doesn’t flourish in a vacuum. Having a ready supply of smartly chosen building blocks like 4-Bromopyridin-2-Ol lets research teams pivot quickly, chase new leads, and scale up promising discoveries efficiently. In my own collaborative work with both academic and industrial chemists, those who keep their intermediary stocks current and versatile consistently outpace teams working with a narrower, less adaptable toolkit.
Long-term, the expansion of research into unexplored chemical space will only accelerate. Versatile intermediates that can serve dual roles without introducing new regulatory complications provide a competitive edge. Feedback from principal investigators in diverse institutions consistently points to practical, versatile reagents as essential ingredients for sustainable innovation. Building a chemical inventory driven by this mindset pays off in both productivity and morale.
Sustainability concerns continue to influence procurement decisions across both academia and industry. Choosing reagents that slot into well-documented disposal pathways, require less organic solvent, and streamline synthesis fits well with both budget and environmental priorities. With the research community working toward greener, more responsible chemistry, reagents like 4-Bromopyridin-2-Ol—those enforcing compact, multi-functionality—help set a new standard.
As the search for more effective drugs, advanced materials, and innovative chemical transformations continues, the premium on flexible, reliable intermediates will only increase. Whether you’re running a focused medchem project or assembling a diverse materials library, compounds that can streamline workflows while adhering to established safety and environmental guidelines deserve their place in the regular lineup. Teams who recognize and invest in these advantages often find themselves better prepared for both expected workload and the surprises intrinsic to competitive research.
Every research group faces its own set of constraints, from tight timelines to shifting regulatory guidance. Over the years, I’ve seen that those who build a foundation of adaptable, thoughtfully selected building blocks maneuver these constraints with confidence. 4-Bromopyridin-2-Ol stands out not because it reinvents the wheel, but because it solves targeted problems in a landscape crowded with lesser alternatives. Armed with reliability, flexibility, and strong documentation, it serves both the immediate demands of the bench and the strategic needs of the broader project.
In research, the small choices pile up. Choosing intermediates that do more, waste less, and slot cleanly into established protocols brings long-term dividends. With the growing attention to reproducibility and responsible chemistry, keeping 4-Bromopyridin-2-Ol in stock reflects a choice to value both process and outcome. That’s a pattern worth encouraging across the field, for current projects and the discoveries still to come.
